Manual synthesis bottlenecked research. Chemists now use conversational AI to configure robots that synthesize and test compounds.
A biotechnology firm operates in a pharmaceutical industry where the initial drug discovery phase alone typically takes up to five years and costs over $100 million before clinical trials begin.
The potential number of molecular structures to explore is larger than the number of grains of sand on Earth. Once a promising molecule is...
“It was kind of a revolution in our minds, saying that maybe you can use AI to optimise molecules.”
AI and robotics platform for automated drug discovery and chemical synthesis.
Cloud computing platform and on-demand infrastructure services.
Iktos's Drug discovery is part of this use case:
Related implementations across industries and use cases
Target assessments took a full quarter. Now, AI agents synthesize 1,000+ datasets to finish in hours.
Scientists spent weeks manually searching 38 million files. Agents now finish in minutes, saving 43,000 hours.
Drug developers lost days hunting for research across scattered PDFs. Now, they query an AI agent for instant answers, accelerating R&D.
Target assessments took a full quarter. Now, AI agents synthesize 1,000+ datasets to finish in hours.
Scientists spent weeks manually searching 38 million files. Agents now finish in minutes, saving 43,000 hours.
Agents manually priced 100-item email requests. AI now extracts data and drafts quotes, leaving humans to validate rather than type.
Agencies slowed localization for 90 markets. Now, AI drafts marketing copy, and native speakers verify clinical precision.
Protecting users from harmful on-device AI required internet. A powerful safety AI now runs directly on the PC, guarding users even when offline.
A 200% yearly data expansion bottlenecked global operations. Now, AI accelerates coding, drafts recipe cards, and resolves inquiries.
Manual synthesis bottlenecked research. Chemists now use conversational AI to configure robots that synthesize and test compounds.
A biotechnology firm operates in a pharmaceutical industry where the initial drug discovery phase alone typically takes up to five years and costs over $100 million before clinical trials begin.
The potential number of molecular structures to explore is larger than the number of grains of sand on Earth. Once a promising molecule is...
“It was kind of a revolution in our minds, saying that maybe you can use AI to optimise molecules.”
AI and robotics platform for automated drug discovery and chemical synthesis.
Cloud computing platform and on-demand infrastructure services.
Iktos's Drug discovery is part of this use case:
Related implementations across industries and use cases
Target assessments took a full quarter. Now, AI agents synthesize 1,000+ datasets to finish in hours.
Scientists spent weeks manually searching 38 million files. Agents now finish in minutes, saving 43,000 hours.
Drug developers lost days hunting for research across scattered PDFs. Now, they query an AI agent for instant answers, accelerating R&D.
Target assessments took a full quarter. Now, AI agents synthesize 1,000+ datasets to finish in hours.
Scientists spent weeks manually searching 38 million files. Agents now finish in minutes, saving 43,000 hours.
Agents manually priced 100-item email requests. AI now extracts data and drafts quotes, leaving humans to validate rather than type.
Agencies slowed localization for 90 markets. Now, AI drafts marketing copy, and native speakers verify clinical precision.
Protecting users from harmful on-device AI required internet. A powerful safety AI now runs directly on the PC, guarding users even when offline.
A 200% yearly data expansion bottlenecked global operations. Now, AI accelerates coding, drafts recipe cards, and resolves inquiries.